Search Results 301-310 of 45113 for Two-phase

1. Belantamab, Lenalidomide, And Daratumumab For Newly-diagnosed Multiple Myeloma - Mayo Clinic

   ... phase 2 portion of the trial. This trial is exploring the use of a new drug ... This will be given along with 2 with two other drugs, lenalidomide and daratumumab ...

2. Hematology - Clinical trials

   In Part 2, the step-up dose identified in Part 1 will be used followed by ... phase II dose (RP2D of APG2575 in combination with Pomalidomide ...

3. Hematology - Clinical trials

   The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma ...

4. Impact Of 1 Mg Osilodrostat Therapy On Mild Autonomous Cortisol Secretion (MACS) - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

5. A Dose-Escalation And Expansion Study Of BGB-16673 In Participants With B-Cell Malignancies - Mayo Clinic

   About this study. Study consists of two main parts to explore BGB-16673 recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose ...

6. Hantavirus pulmonary syndrome - Symptoms & causes - Mayo Clinic

   Often symptoms start about 2 to 4 weeks after exposure. Hantavirus pulmonary syndrome advances through two distinct stages. In the first stage, which can ...

7. Clinical trials - Oncology (Medical)

   Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to ...

8. SUPRAME-ACTengine® IMA203 Vs. Investigator's Choice Of Treatment In Previously Treated, Unresectable Or Metastatic Cutaneous Melanoma - Mayo Clinic

   Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

9. Zanzalintinib Versus Everolimus In Participants With Locally Advanced Or Metastatic Neuroendocrine Tumors - Mayo Clinic

   Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

10. Study Of The EZH2 Inhibitor Tazemetostat In Malignant Mesothelioma - Mayo Clinic

    This is a Phase 2, multicenter, open-label, 2-part, single-arm, 2-stage study of tazemetostat 800 mg two times a day (BID) administered orally. Screening of ...